Lacson: Pricing for COVID-19 vaccine remains a 'hanging issue' despite Senate inquiries

 By Deighton Acuin and Archie Villaflores

PHOTO: Philippine Daily Inquirer

Senator Panfilo Lacson said Monday the prices of coronavirus vaccines remains a “hanging issue” despite inquiries conducted by the country’s Senate.

“Most of the concerns have been addressed during the three hearings, especially on the third hearing or after we had this informal hearing with [vaccine czar] Sec. [Carlito] Galvez,” Lacson said in an interview with CNN Philippines’ The Source.

“Maraming na-resolve na issues but then one hanging issue is on the prices or the pricing of particularly Sinovac,” he stressed.

Earlier, Galvez still did not disclose the price sealed with Chinese pharmaceutical firm Sinovac, but assured the Philippines is at an “advantage.”

Malacañang also said each vaccine dose only priced near P650 but not exceed P700 — a rate Lacson confirmed to Galvez relayed to him and his fellow lawmakers during the meeting last week.

Despite the issues, the lawmaker expressed hopes the public enlightened with the important aspects on government’s vaccine rollout plan.

“Medyo namulat din and I think assuming that there was an attempt at overpricing – siguro may na-achieve din ‘yung Senado para ma-preempt if ever there was an attempt at overpricing,” Lacson noted.